Chuck Brynelsen is a global executive with over four decades experience developing and commercializing innovative medical technologies. From 2017-2021 he was President of Abbott’s Vascular business. Since retiring from Abbott Chuck has been working on being a grandfather and advising private equity and venture capital firms.
